• Skip to primary navigation
  • Skip to main content
  • Skip to footer
  • Skip to investors navigation
Scholar Rock

Scholar Rock

Discovery and Development of Innovative Medicines

  • Careers
  • Newsroom
  • Contact Us
  • Patients & Families
    • Patients & Families
    • Areas of Focus
      • Spinal Muscular Atrophy
    • Patient Stories
    • Clinical Trials
    • Resources
    • Expanded Access

    Learn about our commitment to creating possibilities for those living with serious disease.

    Patients & Families

  • Our Company
    • Our Company
    • Mission & Vision
    • Newsroom
    • Careers
    • Management Team
    • Board of Directors

    Meet Scholar Rock, a biopharmaceutical company committed to improving lives.

    Our Company

  • Our Science
    • Our Science
    • Platform
    • Publications & Posters

    Discover how our breakthrough approach treats complex disease at its biological root.

    Our Science

  • Our Pipeline
    • Our Pipeline
    • Neuromuscular and Obesity
      • Spinal Muscular Atrophy
      • Cardiometabolic Disorders
    • Immuno-Oncology
      • Cancer (solid tumors)
    • Fibrotic Diseases
      • Fibrosis
    • Hematology
      • Anemia
  • Investors & Media
    • Investor Overview
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financials & Filinigs
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR or Media
Home Our Company Management Team Beth Shafer, Ph.D.
Beth Shafer, Ph.D. Photo

Beth Shafer, Ph.D.

Chief Business Officer

Beth Shafer joined Scholar Rock in August 2024 as Chief Business Officer, responsible for corporate strategy and business development. She is a seasoned healthcare executive with 20 years of experience in the biomedical industry and is known for her leadership in corporate and business development in the fields of neurosciences, gastroenterology, drug discovery, ophthalmology, and pipeline externalization at prominent biopharmaceutical companies. Prior to Scholar Rock, Beth served as a Venture Partner to Mubadala Capital Ventures and as Voyager’s Chief Business Officer. Her experience also includes being Vice President and Head of R&D Business Development at Takeda, where she led Gastrointestinal & Inflammation, Neuroscience, Drug Discovery Sciences, Externalizations BD groups from 2018-2023. Previously, Beth held multiple corporate and business development roles of increasing responsibility during her tenures at Takeda, Novartis and Roche. Prior to joining Takeda, Beth served as Head, Ophthalmology and Exploratory Disease Area (DAx) Business Development & Licensing at Novartis Institutes for Biomedical Research. Prior to that role, she served as Director, Business Development & Licensing at Roche. Beth has also served as a member of the Board of Directors for Aquinnah Pharmaceuticals and Arcellx Inc. She received her Ph.D. in Neuroscience from University of California, San Diego, her M.Phil. and M.A in neuroscience from Columbia University Vagelos College of Physicians and Surgeons, and her B.A. from Rutgers University.

Return to Management Team

Footer

Scholar Rock, Inc.
301 Binney Street, 3rd Floor
Cambridge, MA 02142

Phone: 857.259.3860
[email protected]

LinkedIn X, formally Twitter
© 2025 All Rights Reserved
  • Community Guidelines
  • Expanded Access
  • Privacy Policy
  • Terms of Use

We are Scholar Rock.

A biopharmaceutical company dedicated to discovering, developing, and delivering therapies that create new possibilities for patients.

Learn More About Our Pipeline

  • Community Guidelines
  • Expanded Access
  • Privacy Policy
  • Terms of Use
logo
  • Patients & Families
    • Areas of Focus
      • Spinal Muscular Atrophy
    • Patient Stories
    • Clinical Trials
    • Resources
    • Expanded Access
  • Our Company
    • Mission & Vision
    • Newsroom
    • Careers
    • Management Team
    • Board of Directors
    • Partnering
  • Our Science
    • Platform
    • Publications & Posters
  • Our Pipeline
    • Neuromuscular and Obesity
      • Spinal Muscular Atrophy
      • Cardiometabolic Disorders
    • Immuno-Oncology
      • Cancer (solid tumors)
    • Fibrotic Diseases
      • Fibrosis
    • Hematology
      • Anemia
  • Investors & Media
    • Press Releases
      • Archived Press Releases
    • Events & Presentations
    • Corporate Governance
      • Management Team
      • Board of Directors
      • Committee Composition
    • Financials & Filings
      • SEC Filings
    • Stock Information
      • Historical Stock Lookup
      • Investment Calculator
      • Analyst Coverage
    • Investor FAQs
    • Contact IR or Media
  • Careers
  • Newsroom
  • Contact Us

You are now leaving the Scholar Rock website.

This external link is provided for your convenience. Scholar Rock is not responsible for content on external websites.

Continue